{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:22:59Z","timestamp":1794424979556,"version":"4.9.1"},"reference-count":55,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W020556\/1"],"award-info":[{"award-number":["MR\/W020556\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Medical Research Foundation","award":["MRF-044-0004-F-GILL-C0823"],"award-info":[{"award-number":["MRF-044-0004-F-GILL-C0823"]}]},{"name":"Rosetrees\/Stoneygate Trust","id":[{"id":"https:\/\/ror.org\/00vbd1e96","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NIH","award":["R01AI55182"],"award-info":[{"award-number":["R01AI55182"]}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","award":["SGL021\/1030"],"award-info":[{"award-number":["SGL021\/1030"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["CL-2021-13-002"],"award-info":[{"award-number":["CL-2021-13-002"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2025,11,18]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic hepatitis B virus (HBV) infection disproportionately affects people living with HIV, who are often excluded from functional cure studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      This study investigates CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell profiles in HBV mono-infection versus HBV\/HIV co-infection, examining the impact of long-term therapy on virus-specific responses to inform therapeutic strategies for immune restoration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>\n                      We analysed CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell responses in 61 participants (HBV n=20, HBV\/HIV n=20, HIV n=21), on suppressive antiviral therapy, assessing transcriptomic and proteomic profiles, focusing on exhaustion markers alongside virus-specific functional capabilities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptomic analysis revealed distinct signatures in co-infection, with upregulation of TCR signalling genes, inhibitory pathways and progenitor-exhausted markers (\n                      <jats:italic>XCL2, TCF7, PDCD1, IL7R<\/jats:italic>\n                      ). This profile scored highly for a precursor exhausted (Tpex) CD8\n                      <jats:sup>+<\/jats:sup>\n                      T\u2009cell signature, reflecting stemness that maintains plasticity despite chronic antigen exposure. Proteomic analysis confirmed higher frequencies of Tpex (TCF-1\n                      <jats:sup>+<\/jats:sup>\n                      CD127\n                      <jats:sup>+<\/jats:sup>\n                      PD-1\n                      <jats:sup>+<\/jats:sup>\n                      ) CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells in co-infection, while HBV mono-infection showed predominance of terminally exhausted Tox\n                      <jats:sup>high<\/jats:sup>\n                      TCF-1\n                      <jats:sup>-<\/jats:sup>\n                      CD127\n                      <jats:sup>-<\/jats:sup>\n                      cells. Tpex enrichment extended to HBV-specific populations corresponding with more robust, polyfunctional HBV-specific responses in co-infection against surface and core antigens. HBV-specific CD8 T cells maintained enhanced proliferative capacity and checkpoint responsiveness to anti-PDL1 blockade compared with HBV mono-infection. While co-infection was characterised by lower HBsAg levels and longer treatment duration, these factors alone did not account for the distinct immunological profiles.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      People with well-controlled HBV\/HIV co-infection maintain robust CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell responses with preserved stem-like properties supporting antiviral function. These results challenge assumptions about additive immune dysfunction in dual chronic infections and highlight the need for tailored immune-modulatory therapies.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2025-335461","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:07:12Z","timestamp":1764842832000},"page":"1397-1410","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Stem-like CD8+ T cells preserve HBV-specific responses in HBV\/HIV co-infection"],"prefix":"10.1136","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-0058","authenticated-orcid":false,"given":"Anucha","family":"Preechanukul","sequence":"first","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljawharah","family":"Alrubayyi","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Arbe-Barnes","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonida","family":"Kokici","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Gorou","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarun","family":"Prasitdumrong","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A S","family":"da Costa","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Fisher-Pearson","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noshin","family":"Hussain","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kucykowicz","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrajit","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Mortimer Market Clinic, Central Northwest London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, UK"},{"name":"Institute for Global Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kinloch","sequence":"additional","affiliation":[{"name":"Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Simoes","sequence":"additional","affiliation":[{"name":"Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bhagani","sequence":"additional","affiliation":[{"name":"Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-0094","authenticated-orcid":false,"given":"Patrick T F","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Barts Liver Centre, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6384-1462","authenticated-orcid":false,"given":"Mala K","family":"Maini","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Bashford-Rogers","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upkar S","family":"Gill","sequence":"additional","affiliation":[{"name":"Barts Liver Centre, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9281-5471","authenticated-orcid":false,"given":"Dimitra","family":"Peppa","sequence":"additional","affiliation":[{"name":"Institute of Immunity and Transplantation, University College London, London, UK"},{"name":"Mortimer Market Clinic, Central Northwest London NHS Foundation Trust, London, UK"},{"name":"Department of HIV Medicine, Royal Free London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2026111106400857000_75.7.1397.1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13217"},{"key":"2026111106400857000_75.7.1397.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00549-4"},{"key":"2026111106400857000_75.7.1397.3","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02844-06"},{"key":"2026111106400857000_75.7.1397.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PLoS One"},{"key":"2026111106400857000_75.7.1397.5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24249"},{"key":"2026111106400857000_75.7.1397.6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327202"},{"key":"2026111106400857000_75.7.1397.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.06.078"},{"key":"2026111106400857000_75.7.1397.8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.019"},{"key":"2026111106400857000_75.7.1397.9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001574"},{"key":"2026111106400857000_75.7.1397.10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00183-09"},{"key":"2026111106400857000_75.7.1397.11","doi-asserted-by":"publisher","DOI":"10.1086\/379896"},{"key":"2026111106400857000_75.7.1397.12","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz450"},{"key":"2026111106400857000_75.7.1397.13","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002386"},{"key":"2026111106400857000_75.7.1397.14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/HEP.0000000000000877","article-title":"HIV\/HBV coinfection remodels the immune landscape and natural killer cell ADCC functional responses","volume":"80","author":"Sun","year":"2024","journal-title":"Hepatology"},{"key":"2026111106400857000_75.7.1397.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01219-w"},{"key":"2026111106400857000_75.7.1397.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.021"},{"key":"2026111106400857000_75.7.1397.17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature New Biol"},{"key":"2026111106400857000_75.7.1397.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01097-3"},{"key":"2026111106400857000_75.7.1397.19","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2021.04.048"},{"key":"2026111106400857000_75.7.1397.20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cels.2020.05.010","article-title":"Solo: Doublet Identification in Single-Cell RNA-Seq via Semi-Supervised Deep Learning","volume":"11","author":"Bernstein","year":"2020","journal-title":"Cell Syst"},{"key":"2026111106400857000_75.7.1397.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0276-y"},{"key":"2026111106400857000_75.7.1397.22","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-016-0384-y","article-title":"XGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits","volume":"8","author":"Fang","year":"2016","journal-title":"Genome Med"},{"key":"2026111106400857000_75.7.1397.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-01033-z"},{"key":"2026111106400857000_75.7.1397.24","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"2026111106400857000_75.7.1397.25","doi-asserted-by":"crossref","unstructured":"Moinfar AA , Theis FJ . Unsupervised deep disentangled representation of single-cell omics. bioRxiv [Preprint] 2024. doi:10.1101\/2024.11.06.622266","DOI":"10.1101\/2024.11.06.622266"},{"key":"2026111106400857000_75.7.1397.26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26137-7","article-title":"Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV","volume":"12","author":"Alrubayyi","year":"2021","journal-title":"Nat Commun"},{"key":"2026111106400857000_75.7.1397.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.01.041"},{"key":"2026111106400857000_75.7.1397.28","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00262.2014"},{"key":"2026111106400857000_75.7.1397.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2013.05.004"},{"key":"2026111106400857000_75.7.1397.30","doi-asserted-by":"publisher","DOI":"10.1177\/117727190700200023"},{"key":"2026111106400857000_75.7.1397.31","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201643103"},{"key":"2026111106400857000_75.7.1397.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.01.001"},{"key":"2026111106400857000_75.7.1397.33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001348"},{"key":"2026111106400857000_75.7.1397.34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature New Biol"},{"key":"2026111106400857000_75.7.1397.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6"},{"key":"2026111106400857000_75.7.1397.36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100102"},{"key":"2026111106400857000_75.7.1397.37","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jgh3.12321","article-title":"Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance","volume":"4","author":"Taniguchi","year":"2020","journal-title":"JGH Open"},{"key":"2026111106400857000_75.7.1397.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-00817-w"},{"key":"2026111106400857000_75.7.1397.39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.035"},{"key":"2026111106400857000_75.7.1397.40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136648","article-title":"TCF-1 regulates HIV-specific CD8+ T cell expansion capacity","volume":"6","author":"Rutishauser","year":"2021","journal-title":"JCI Insight"},{"key":"2026111106400857000_75.7.1397.41","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316641"},{"key":"2026111106400857000_75.7.1397.42","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15050","article-title":"TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat Commun"},{"key":"2026111106400857000_75.7.1397.43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41586-024-08451-4","article-title":"Precursors of exhausted T cells are pre-emptively formed in acute infection","volume":"640","author":"Chu","year":"2025","journal-title":"Nature New Biol"},{"key":"2026111106400857000_75.7.1397.44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41586-024-08562-y","article-title":"An early precursor CD8+ T cell that adapts to acute or chronic viral infection","volume":"640","author":"McManus","year":"2025","journal-title":"Nature New Biol"},{"key":"2026111106400857000_75.7.1397.45","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322404"},{"key":"2026111106400857000_75.7.1397.46","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332526"},{"key":"2026111106400857000_75.7.1397.47","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100067","article-title":"Characterisation of HBV and co-infection with HDV and HIV through spatial transcriptomics","volume":"2","author":"Cross","year":"2024","journal-title":"eGastroenterology"},{"key":"2026111106400857000_75.7.1397.48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007797","article-title":"NK cell-intrinsic Fc\u03b5RI\u03b3 limits CD8+ T-cell expansion and thereby turns an acute into a chronic viral infection","volume":"15","author":"Duhan","year":"2019","journal-title":"PLoS Pathog"},{"key":"2026111106400857000_75.7.1397.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.008"},{"key":"2026111106400857000_75.7.1397.50","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhepr.2019.07.007","article-title":"Is PD-1 blockade a potential therapy for HBV?","volume":"1","author":"F\u00e9ray","year":"2019","journal-title":"JHEP Rep"},{"key":"2026111106400857000_75.7.1397.51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103840","article-title":"Immune checkpoint blockade in HIV","volume":"76","author":"Gubser","year":"2022","journal-title":"EBioMedicine"},{"key":"2026111106400857000_75.7.1397.52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abl3836","article-title":"Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy","volume":"14","author":"Uldrick","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026111106400857000_75.7.1397.53","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157549","article-title":"Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control","volume":"132","author":"Perdomo-Celis","year":"2022","journal-title":"J Clin Invest"},{"key":"2026111106400857000_75.7.1397.54","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108666","article-title":"IL-15 boosts activated HBV core-specific CD8+ progenitor cells via metabolic rebalancing in persistent HBV infection","volume":"27","author":"Pe\u00f1a-Asensio","year":"2024","journal-title":"iScience"},{"key":"2026111106400857000_75.7.1397.55","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ado3032","article-title":"Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate","volume":"10","author":"Huang","year":"2025","journal-title":"Sci Immunol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2025-335461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:41:40Z","timestamp":1794408100000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2025-335461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6,9]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/gutjnl-2025-335461"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2025-335461","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}